Drug design strategies against newly emerging viral diseases KU Leuven
The proposed project aims at the structure-based design of novel selective inhibitors for the treatment of specific vector-borne diseases mainly parasitic (schistosomiasis, human African trypanosomiasis, leishmaniasis, Chagas disease) and viral hemorrhagic fevers. It will be a challenging task to find those compounds that have maximal efficacy against the intruder, but minimal toxicity for the host as the differences between few parasitic ...